It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

By adapting artificial intelligence models known as large language models, researchers have made great progress in their ...

Achievement strengthens iBio’s partnered cardiometabolic and obesity program while showcasing its proprietary AI-driven drug ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Numerous court decisions over the past decade – such as Amgen Inc. v. Sanofi from the US Supreme Court and Juno Therapeutics, Inc. et al. v.

Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today ...

NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Adcentrx begins patient dosing in phase 1a/b study of ADRX-0405, a potential first-in-class ADC targeting STEAP1 to treat advanced solid tumours: San Diego, California Wednesday, ...

Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platformBrings ...

New antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ...